Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Cash Flows

v3.5.0.2
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Statement of Cash Flows [Abstract]    
Cash and cash equivalents, beginning of period $ 15,308 $ 2,561
Cash flows provided by (used for) operating activities:    
Net income 6,754 7,807
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 4,684 5,885
Share-based compensation 1,136 1,009
Restructuring and other charges 1,786 367
Excess tax benefit from share-based payment arrangements (111) (139)
Amortization of intangibles 1,176 680
(Gains) losses on equity investments, net (414) (245)
Deferred taxes (188) (1,093)
Changes in assets and liabilities:    
Accounts receivable (100) 332
Inventories (118) (640)
Accounts payable 188 (86)
Accrued compensation and benefits (1,874) (1,217)
Income taxes payable and receivable 961 774
Other assets and liabilities (222) 156
Total adjustments 6,904 5,783
Net cash provided by operating activities 13,658 13,590
Cash flows provided by (used for) investing activities:    
Additions to property, plant and equipment (6,095) (4,998)
Acquisitions, net of cash acquired (15,151) (538)
Purchases of available-for-sale investments (7,962) (7,522)
Sales of available-for-sale investments 3,793 1,040
Maturities of available-for-sale investments 4,928 2,153
Purchases of trading assets (9,953) (7,943)
Maturities and sales of trading assets 7,867 10,465
Investments in loans receivable and reverse repurchase agreements (223) (2,550)
Collection of loans receivable and reverse repurchase agreements 911 466
Investments in non-marketable equity investments (893) (1,864)
Other investing 405 380
Net cash used for investing activities (22,373) (10,911)
Cash flows provided by (used for) financing activities:    
Increase (decrease) in short-term debt, net 426 (473)
Excess tax benefit from share-based payment arrangements 111 139
Issuance of long-term debt, net of issuance costs 2,734 7,986
Proceeds from sales of common stock through employee equity incentive plans 1,024 696
Repurchase of common stock (2,054) (2,476)
Restricted stock unit withholdings (434) (416)
Payment of dividends to stockholders (3,692) (3,423)
Collateral associated with repurchase of common stock 0 325
Decrease in liability due to return of collateral associated with repurchase of common stock 0 (325)
Other financing 44 (209)
Net cash provided by (used for) financing activities (1,841) 1,824
Effect of exchange rate fluctuations on cash and cash equivalents 0 1
Net increase (decrease) in cash and cash equivalents (10,556) 4,504
Cash and cash equivalents, end of period 4,752 7,065
Supplemental disclosures of noncash investing activities and cash flow information:    
Acquisition of property, plant, and equipment included in accounts payable and accrued liabilities 1,505 460
Interest, net of capitalized interest and interest rate swap payments/receipts 472 60
Income taxes, net of refunds $ 843 $ 2,301